Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Regulatory News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

12 Apr 2022 07:00

RNS Number : 0348I
Sensyne Health PLC
12 April 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BYV3J755

Issuer Name

SENSYNE HEALTH PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Baillie Gifford & Co

City of registered office (if applicable)

Edinburgh

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

08-Apr-2022

6. Date on which Issuer notified

11-Apr-2022

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.000000

0.000000

0.000000

0

Position of previous notification (if applicable)

 

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BYV3J755

 

0

 

0.000000

Sub Total 8.A

0

0.000000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

 

 

 

 

Sub Total 8.B1

 

 

 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

 

 

 

 

 

Sub Total 8.B2

 

 

 

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Baillie Gifford & Co

 

 

 

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

11 April 2022

13. Place Of Completion

Edinburgh

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLKZGMDLMZGZZM
Date   Source Headline
19th Aug 20202:00 pmRNSPrice Monitoring Extension
19th Aug 20207:00 amRNSDevelopment of ‘DBm-Health™’ for diabetes
17th Aug 20204:41 pmRNSSecond Price Monitoring Extn
17th Aug 20204:36 pmRNSPrice Monitoring Extension
13th Aug 20202:06 pmRNSSecond Price Monitoring Extn
13th Aug 20202:00 pmRNSPrice Monitoring Extension
10th Aug 20207:00 amRNSSensyne Health settles employment tribunal claim
20th May 202011:05 amRNSSecond Price Monitoring Extn
20th May 202011:00 amRNSPrice Monitoring Extension
19th May 20204:00 pmRNSLaunch of CVm-Health app in the US
14th May 20207:00 amRNSTrading and Business Update
5th May 20207:00 amRNSSensyne Health launches BPm-Health product
20th Apr 20207:00 amRNSLaunch of CVm-Health ‘Good Neighbour’ app
9th Apr 20204:41 pmRNSSecond Price Monitoring Extn
9th Apr 20204:37 pmRNSPrice Monitoring Extension
30th Mar 20202:05 pmRNSSecond Price Monitoring Extn
30th Mar 20202:00 pmRNSPrice Monitoring Extension
27th Mar 20204:42 pmRNSSecond Price Monitoring Extn
27th Mar 20204:37 pmRNSPrice Monitoring Extension
27th Mar 20202:52 pmRNSGDm-Health free to NHS in response to COVID-19
11th Mar 20209:00 amRNSHolding(s) in Company
2nd Mar 20205:29 pmRNSInterim Chief Financial Officer appointment
2nd Mar 20208:18 amRNSDirectorate Change
28th Feb 20204:00 pmRNSHSJ Partnership Award for GDm-Health
3rd Feb 20207:00 amRNSHoldings in Company
21st Jan 20207:00 amRNSSensyne Health confirms benefits in study
21st Jan 20207:00 amRNSSensyne Health Interim Results
16th Jan 20202:05 pmRNSSecond Price Monitoring Extn
16th Jan 20202:00 pmRNSPrice Monitoring Extension
23rd Dec 20197:00 amRNSSensyne Health enters AI research collaboration
20th Dec 20199:00 amRNSNotice of Results
16th Dec 20197:00 amRNSUpdate Following General Election
10th Dec 20197:00 amRNSBoard Changes
15th Nov 20197:00 amRNSCognizant and Agorai named as partners
30th Oct 20192:28 pmRNSResult of AGM
30th Oct 20197:41 amRNSDirectorate Change
22nd Oct 20197:00 amRNSAppointment of Joint Broker and Financial Adviser
22nd Oct 20197:00 amRNSRemuneration Policy and Corporate Governance
17th Oct 20195:21 pmRNSHolding(s) in Company
15th Oct 20195:16 pmRNSHolding(s) in Company
10th Oct 20197:00 amRNSSensyne extends partnership with Bayer
7th Oct 20197:00 amRNSAnnual Report and Accounts
7th Oct 20197:00 amRNSCollaboration with UK MHRA
7th Oct 20197:00 amRNSMajor Agreements for digital health products in US
7th Oct 20197:00 amRNSSensyne Health Maiden Full Year Results
4th Oct 20197:00 amRNSBoard Change
4th Oct 20197:00 amRNSRelated party transactions
23rd Sep 201912:00 pmRNSBoard Change
12th Sep 20197:00 amRNSNotice of Full Year Results
2nd Aug 201912:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.